Stephens Consulting, LLC Kempharm, Inc Transaction History
Stephens Consulting, LLC
- $326 Billion
- Q1 2024
A detailed history of Stephens Consulting, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 2,000 shares of KMPH stock, worth $9,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$9,880
Previous $13.1 Million
11.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KMPH
# of Institutions
94Shares Held
13.8MCall Options Held
68.1KPut Options Held
42K-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$11.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.7MShares$8.42 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.01MShares$4.99 Million0.05% of portfolio
-
683 Capital Management, LLC New York, NY800KShares$3.95 Million0.34% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...